Cann Group Ltd. (AU:CAN) has released an update.
Cann Group Limited is advancing its mission to improve patient lives through innovative cannabis medicines, with facilities in Melbourne and a large-scale cultivation and manufacturing site in Mildura. The company offers a variety of products, including dried flowers, oils, and pharmaceutical ingredients, and has expanded its portfolio with Satipharm’s patented capsule technology.
For further insights into AU:CAN stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- No Resolution Between Paramount Global (NASDAQ:PARA) and Nielsen
- Ford (NYSE:F) Enters Mustang Mach-E in Road Rally
- Concerns Growing Over Intel (NASDAQ:INTC) Battlemage Line
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
